Completed NA INTERVENTIONAL 2-arm NCT01672242

Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)

Sponsor: University of Maryland, Baltimore

Interventions CPAP HFNC

Updated 11 times since 2017 Last updated: Mar 4, 2022 Started: Jul 31, 2012 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Healthy Adult Volunteers and is currently completed. University of Maryland, Baltimore leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Apr 2022 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 6 earlier versions

Sep 2019 — Feb 2020 [monthly]

Completed NA
Jun 2018 — Sep 2019 [monthly]

Completed NA
Mar 2018 — Jun 2018 [monthly]

Completed NA
Jan 2018 — Mar 2018 [monthly]

Completed NA

Phase: PHASE4 → NA
Feb 2017 — Jan 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Maryland, Baltimore
Vapotherm, Inc.

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States